Featured Research

from universities, journals, and other organizations

MRI Study Shows Hormone Leptin Alters Brains, May Ease Cravings Of People With Obesity Gene

Date:
May 3, 2005
Source:
University of California Los Angeles -- Health Sciences
Summary:
A magnetic resonance imaging (MRI) study finds that the protein hormone leptin promotes development of gray matter in the part of the brain that regulates cravings and the ability to monitor personal behavior. The findings suggest Leptin may play a role in modulating personal behavior and perhaps food cravings.

A magnetic resonance imaging (MRI) study finds that the protein hormone leptin promotes development of gray matter in the part of the brain that regulates cravings and the ability to monitor personal behavior. After receiving leptin replacement therapy, research subjects with a recessive mutation in the obesity (ob) gene -- a population both deficient in Leptin and morbidly obese -- lost about half of their body weight while regulating their own food intake.

The findings suggest Leptin may play a role in modulating personal behavior and perhaps food cravings.

Leptin is a protein hormone that plays an important role in regulating body weight, metabolism and reproductive function. Researchers took MRI scans of research subjects' brains prior to beginning leptin replacement treatment, and again at six and 18 months after treatment began.

The lead investigators are Drs. Edythe London and Julio Licinio of the UCLA Neuropsychiatric Institute. The imaging was conducted by Dr. London and John Matochik of the National Institute on Drug Abuse.

###

Journal: Journal of Clinical Endocrinology & Metabolism (May 2005).

Funders: National Institutes of Health (National Institutes of General Medical Sciences, National Center for Research Resources, National Institute of Mental Health, National Institute on Drug Abuse).


Story Source:

The above story is based on materials provided by University of California Los Angeles -- Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University of California Los Angeles -- Health Sciences. "MRI Study Shows Hormone Leptin Alters Brains, May Ease Cravings Of People With Obesity Gene." ScienceDaily. ScienceDaily, 3 May 2005. <www.sciencedaily.com/releases/2005/05/050503152956.htm>.
University of California Los Angeles -- Health Sciences. (2005, May 3). MRI Study Shows Hormone Leptin Alters Brains, May Ease Cravings Of People With Obesity Gene. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2005/05/050503152956.htm
University of California Los Angeles -- Health Sciences. "MRI Study Shows Hormone Leptin Alters Brains, May Ease Cravings Of People With Obesity Gene." ScienceDaily. www.sciencedaily.com/releases/2005/05/050503152956.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins